GOSSVSSUPN• 28 Days (Normalized)
GOSS vs SUPN (Gossamer Bio Inc. vs Supernus Pharmaceuticals Inc.)
Showing Closing Date Range from Aug, 14 to Sep, 11, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
GOSS Performance $10.73
+6867.53%
Gossamer Bio Inc.
Normalized Baseline0.00%
SUPN Performance $41.64
-13.74%
Supernus Pharmaceuticals Inc.
Normalized Baseline0.00%
Alpha Spread Margin GOSS LEADS
+6881.27%
GOSS outperforming by 6881.27%
GOSSSUPN
Spread Trajectory28 Days (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
GOSS SUPN
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(20 dates)
| Date | GOSS Price | GOSS Gain (%) | SUPN Price | SUPN Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 11, 2026 | $10.73 | +6867.53% | $41.64 | -13.74% | +6881.27% |
| Sep 10, 2026 | $11.36 | +7276.62% | $41.69 | -13.63% | +7290.25% |
| Sep 09, 2026 | $12.80 | +8211.69% | $42.07 | -12.84% | +8224.53% |
| Sep 08, 2026 | $14.40 | +9250.65% | $42.43 | -12.10% | +9262.75% |
| Sep 04, 2026 | $14.00 | +8990.91% | $43.53 | -9.82% | +9000.73% |
| Sep 03, 2026 | $14.05 | +9022.08% | $43.97 | -8.91% | +9030.99% |
| Sep 02, 2026 | $0.17 | +12.34% | $44.03 | -8.78% | +21.12% |
| Sep 01, 2026 | $0.17 | +8.44% | $43.74 | -9.38% | +17.82% |
| Aug 31, 2026 | $0.17 | +10.39% | $44.21 | -8.41% | +18.80% |
| Aug 28, 2026 | $0.17 | +10.39% | $43.73 | -9.41% | +19.80% |
| Aug 27, 2026 | $0.17 | +10.39% | $44.19 | -8.45% | +18.84% |
| Aug 26, 2026 | $0.17 | +12.99% | $44.88 | -7.02% | +20.01% |
| Aug 25, 2026 | $0.21 | +33.12% | $45.36 | -6.03% | +39.15% |
| Aug 24, 2026 | $0.18 | +13.64% | $45.11 | -6.55% | +20.19% |
| Aug 21, 2026 | $0.16 | +0.65% | $45.85 | -5.01% | +5.66% |
Page 1 of 2